A DGIST research team has developed a microrobot that can accurately reach the location of cardiovascular problems such as chronic total occlusion by moving and steering toward a desired direction inside blood vessels. This ...
Mar 6, 2019
0
0
(HealthDay)—The presence of comorbid chronic kidney disease (CKD) negatively impacts myocardial revascularization outcomes in patients with type 2 diabetes mellitus (T2DM), according to a study published in the Feb. 5 issue ...
Feb 27, 2019
0
2
(HealthDay)—The benefits of postconditioning (PostC) balloon inflations in patients with ST-segment-elevation myocardial infarction (STEMI) undergoing percutaneous coronary intervention (PCI) may not be apparent immediately, ...
Feb 7, 2019
0
2
(HealthDay)—Unprotected left main (ULM) percutaneous coronary intervention (PCI) procedures represented less than 1 percent of all PCIs in clinical practice in the United States from 2009 through 2016, according to a study ...
Jan 3, 2019
0
0
A new randomised trial of over 3000 people in The Lancet finds that sharing pictorial representations of personalised scans showing the extent of atherosclerosis (vascular age and plaque in the arteries) to patients and their ...
Dec 4, 2018
0
0
In the largest such study undertaken to date, research led by Keele University suggests that patients with cancer who undergo a common heart procedure have worse short-term clinical outcomes compared to non-cancer patients, ...
Dec 3, 2018
0
0
(HealthDay)—For patients with diabetes mellitus (DM) with multivessel coronary disease (MVD), coronary revascularization with coronary artery bypass grafting (CABG) is associated with lower all-cause mortality than percutaneous ...
Nov 15, 2018
0
0
(HealthDay)—For patients with left main coronary artery disease (LMCAD), those with and without chronic kidney disease (CKD) undergoing revascularization have similar long-term outcomes with percutaneous coronary intervention ...
Sep 27, 2018
0
0
(HealthDay)—The PK Papyrus Covered Coronary Stent System has been approved by the U.S. Food and Drug Administration to treat acute coronary artery perforations, the medical term for tears in the heart's blood vessels.
Sep 15, 2018
0
1
Long-term antiplatelet monotherapy after stenting is safe but does not reduce the risk of death or heart attack compared to standard dual antiplatelet therapy, according to late breaking results from the GLOBAL LEADERS trial ...
Aug 27, 2018
0
3
